146 related articles for article (PubMed ID: 4948452)
1. Systemic reactions to topical therapy.
Ellis PP
Int Ophthalmol Clin; 1971; 11(2):1-11. PubMed ID: 4948452
[No Abstract] [Full Text] [Related]
2. Adverse systemic effects from topical eye drugs.
Med Lett Drugs Ther; 1973 Mar; 15(5):23-4. PubMed ID: 4697471
[No Abstract] [Full Text] [Related]
3. Systemic effects of eye drops.
Davidson SI
Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):487-95. PubMed ID: 4143267
[No Abstract] [Full Text] [Related]
4. [Systemic effects of drugs administered by conjunctival route].
Palmieri N; Cantarini M
Clin Ter; 1987 Jun; 121(6):505-15. PubMed ID: 2973887
[No Abstract] [Full Text] [Related]
5. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications.
Rengstorff RH; Doughty CB
Am J Optom Physiol Opt; 1982 Feb; 59(2):162-77. PubMed ID: 7039329
[TBL] [Abstract][Full Text] [Related]
6. Adverse reactions to topical ocular autonomic agents.
Norden LC
J Am Optom Assoc; 1978 Jan; 49(1):75-80. PubMed ID: 146723
[No Abstract] [Full Text] [Related]
7. [Hypertensive crisis and coma after administration of scopolamine, atropine, and phenylephrine ophthalmic solutions during 2 vitreoretinal operations].
Benatar-Haserfaty J; Tercero-López JQ
Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):440-1. PubMed ID: 12455330
[No Abstract] [Full Text] [Related]
8. [Negative influence of some agents on eye condition in primary glaucoma].
Chrzanowska-Srzednicka K; Ciechanowska A
Przegl Lek; 1972; 29(7):694-8. PubMed ID: 4561299
[No Abstract] [Full Text] [Related]
9. Anticholinesterase drugs and cataracts.
Shaffer RN; Hetherington J
Trans Am Ophthalmol Soc; 1966; 64():204-16. PubMed ID: 6007355
[No Abstract] [Full Text] [Related]
10. Occupational allergic contact dermatitis from homatropine and phenylephrine eyedrops.
Marcos ML; Garcés MM; Alonso L; Juste S; Carretero P; Blanco J; Garcia F; Perez R; Herrero D
Contact Dermatitis; 1997 Oct; 37(4):189. PubMed ID: 9385525
[No Abstract] [Full Text] [Related]
11. [Systemic side effects of topical ophthalmic drugs].
Bodd E; Lunde PK
Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1375. PubMed ID: 2339383
[No Abstract] [Full Text] [Related]
12. Safe use of ocular drugs in the elderly.
Fraunfelder FT; Meyer SM
Geriatrics; 1984 Apr; 39(4):97-102. PubMed ID: 6706121
[No Abstract] [Full Text] [Related]
13. [Nipiopharmacology from the ophthalmological point of view].
Gomirato Sandrucci M; Liuzzi L
Minerva Nipiol; 1968; 18(2):48-50. PubMed ID: 5744923
[No Abstract] [Full Text] [Related]
14. Contact allergy to atropine and other mydriatic agents in eye drops.
Decraene T; Goossens A
Contact Dermatitis; 2001 Nov; 45(5):309-10. PubMed ID: 11722501
[No Abstract] [Full Text] [Related]
15. Toxicity of ocular medications.
Benjamin KW
Int Ophthalmol Clin; 1979; 19(1):199-255. PubMed ID: 376469
[No Abstract] [Full Text] [Related]
16. [Systemic effects of eyedrops].
Le Jeunne C; Hugues FC; Munera Y; Haas C
Ann Med Interne (Paris); 1990; 141(8):674-7. PubMed ID: 1982605
[No Abstract] [Full Text] [Related]
17. Systemic effects of topical ophthalmic medications.
Selvin BL
South Med J; 1983 Mar; 76(3):349-58. PubMed ID: 6131541
[TBL] [Abstract][Full Text] [Related]
18. [Local cholinergic agonists and paradoxal systemic reactions].
Martin X
J Fr Ophtalmol; 1987; 10(2):129-33. PubMed ID: 3611602
[TBL] [Abstract][Full Text] [Related]
19. AUTONOMIC OCULAR DRUGS: DESIRABLE AND UNDESIRABLE EFFECTS.
SHAFFER RN
Invest Ophthalmol; 1964 Oct; 3():498-503. PubMed ID: 14229935
[No Abstract] [Full Text] [Related]
20. How safe are ocular drugs in pediatrics?
Palmer EA
Ophthalmology; 1986 Aug; 93(8):1038-40. PubMed ID: 3763151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
